Asia Pac is so significant that it cannot be ignored. It will play an increasingly important role within the Future Healthcare domain. More than 60% of the world's population are in the Asian-Pacific Markets. The commercial success of the biopharmaceuticals is increasingly becoming the center stage in healthcare. By 2015 we will see the Asian Drug Development taking off to new heights, addressing disease conditions endemics to these regions. That being the need to satisfy, turnkey drug development capabilities will be a competitive advantage.
The players who are positioned with the following will lead the new age healthcare.
1. Wider geographical reach
2. Larger Investigation and Key Opinion Leader (KOL) network.
3. Committed to leverage expertise with technology
4. Maintain high quality standards
5. Partner and Invest with the stakeholders of new age healthcare.
No comments:
Post a Comment